The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial) (ACT-South Asia)
Azithromycin and Cefixime Combination Versus Azithromycin Alone for the Out-patient Treatment of Clinically Suspected or Confirmed Uncomplicated Typhoid Fever in South Asia; a Randomised Controlled Trial
Sponsor: Department for International Development, United Kingdom
This PHASE4 trial investigates Typhoid Fever and is currently completed. Department for International Development, United Kingdom leads this study, which shows 8 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Aug 2025 — Feb 2026 [monthly]
Recruiting PHASE4
-
Sep 2024 — Aug 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Jan 2024 — Jul 2024 [monthly]
Recruiting PHASE4
▶ Show 3 earlier versions
-
Nov 2022 — Jan 2024 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Nov 2022 [monthly]
Not Yet Recruiting PHASE4
-
May 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Department for International Development, United Kingdom
- Medical Research Council
- Oxford University Clinical Research Unit, Vietnam
- University of Oxford
- Wellcome Trust
For direct contact, visit the study record on ClinicalTrials.gov .